Individuals

Individuals who are either patients with IDs or those not formally diagnosed with an ID but at high risk of developing one or more IDs in the near future.

Clinitians

Clinicians and other health care practitioners responsible for the care of patients either with, or at risk of developing, Inflamatory Disseases.

Biopharma

Biopharma companies developing anti-inflammatory therapeutics.